TCL Archive Advisors approve NCI’s revised plan for $104-million proteomics research program. July 8, 2005
TCL Archive FDA News: FDA Approved A Supplemental New Drug Application For Nexavar Tablets (Sorafenib) For The Treatment Of Patients With Locally Recurrent Or Metastatic, Progressive, Differentiated Thyroid Carcinoma Refractory To Radioactive Iodine Treatment. December 17, 2013
TCL Archive Anil Potti Explains: “Coming from India, I Did Not Know This Was Not The Real Rhodes Scholarship” December 16, 2011
